Amendment No. 2 to Third Amended and Restated 10% Convertible Note
Exhibit 10.64(b)
Amendment No. 2 to
Third Amended and Restated 10% Convertible Note
This Amendment No. 2 to Third Amended and Restated 10% Convertible Note effective June 18, 2021 between Cell Source, Inc. (the “Company”) and ▇▇▇▇▇▇▇ ▇▇▇▇▇ (the “Lender”) is effective as of this 28th day of October 2022.
WHEREAS, the Company has previously issued to the Lender an 8% Convertible Note effective October 28, 2019 (the “Original Note”) that was subsequently amended by various amendments, including the Third Amended and Restated 10% Convertible Note (the “Third Amended and Restated Note”) in the principal amount of up to $6,000,000 dated and effective as of June 18, 2021;
WHEREAS, the Company and the Lender wish to extend the Maturity Date of the Third Amended and Restated Note;
NOW THEREFORE, the Company and the Lender hereby agree as follows:
1. | Extension of Maturity Date. The Maturity Date of the Note is hereby extended until April 28, 2023. |
2. | Capitalized Terms. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed in the Note. |
3. | Counterparts. This Amendment may be executed in multiple counterparts, each of which shall be an original, but all of this shall be deemed to constitute one instrument. |
IN WITNESS WHEREOF, the undersigned have executed this Amendment No. 2 as of October 28, 2022
COMPANY | ||
Cell Source, Inc. | ||
By: | /s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
Name: | ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
Title: | President and Chief Executive Officer |
LENDER | |
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇ | |
▇▇▇▇▇▇▇ ▇▇▇▇▇ |